Usefulness of FDG-PET/CT as a Diagnostic Tool for Routine Post Therapy Evaluation in Endometrial Cancer |
Lee, Shin-Jae
(Department of Radiology, CHA Bundang Medical center, CHA University)
Jeon, Tae-Joo (Department of Nuclear medicine, CHA Bundang Medical center, CHA University) Kim, Seung-Jo (Department of Gynecologic Oncology, CHA Bundang Medical center, CHA University) Kim, Hee-Jin (Department of Radiology, CHA Bundang Medical center, CHA University) An, Hee-Jung (Department of pathology, CHA Bundang Medical center, CHA University) |
1 | Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH Detection of early recurrence with F-FOO PET in patients with cervical cancer. J Nucl Med 2003;44:347-52 ScienceOn |
2 | Metser U, Golan O, Levine CD, Even-Sapir E. Tumor lesion detection: when is integrated positron emission tomography/computed tomography more accurate than side-by-side interpretation of positron emission tomography and computed tomography. J Comput Assist Tomogr 2005;29:554-9 DOI ScienceOn |
3 | Saga T, Higashi T, Ishimori T, Mameda M, Nakamoto Y, Mukai T, et al. Clinical value of FDG-PET in the follow up of postoperative patients with endometrial cancer. Ann Nucl Med 2003;17:193-203 PUBMED |
4 | Chao A, Chang TC, Ng KK, Hsueh S, Huang ill, Chou HH, et al. F-FDG PET in the management of endometrial cancer. Eur J Nucl Med Mol Imaging 2006;33:36-44 DOI ScienceOn |
5 | Jemal A, Siegel R, Ward E. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30 DOI ScienceOn |
6 | Aalders JG, Abeler V, Kolstad P. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 1984;17:85-103 DOI ScienceOn |
7 | Connor JP, Andrews JI, Anderson B, Buller RE. Computed tomography in endometrial carcinoma. Obstet Gynecol 2000;95:692-6 DOI ScienceOn |
8 | Chung HH, Kim SK, Kim TH, Lee S, Kang KW, Kim JY, et al. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine celvical cancer: from diagnosis to prognosis. Gynecol Oncol 2006;103:165-70 DOI ScienceOn |
9 | Kim CK, Park BK, Choi JY, Kim BG, Han H. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. J Comput Assist Tomogr 2007;31:868-75 DOI ScienceOn |
10 | Shumsky AG, Stuart GC, Brasher PM, Nation JG. Robertson DI, Sangkara S. An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol 1994;55:229-33 DOI ScienceOn |
11 | Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, et al. The clinical impact of [F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings Eur J Nucl Med Mol Imaging 2008;35:1081-8 DOI ScienceOn |
12 | De Leyn P, Stroobants S, De Wever W, Lerut T, Coosemans W, Decker G, et al. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study. J Clin Oncol 2006;24:3333-9 DOI ScienceOn |
13 | Cherchi PL, Dessole S, Ruiu GA, Ambrosini G, Farina M, Capobianco G, et al. The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma. Eur J Gynaecol Oncol 1999;20:315-7 PUBMED ScienceOn |
14 | Irvin WP, Rice L W, Berkowitz RS. Advances in the management of endometrial adenocarcinoma A review. J Reprod Med 2002;47:173-89 PUBMED ScienceOn |
15 | Salvesen HB, Akslen LA, Iversen T, Iversen OE. Recurrence of endometrial carcinoma and the value of routine follow up. Br J Obstet Gynaecol 1997;104:1302-07 DOI PUBMED ScienceOn |
16 | Jimenez-Bonilla J, Maldonado A, Morales S, Salud A, Zomeno M, Roman J, et al. Clinical impact of F-FDG_PET in the suspicion of recurrent ovarian carcinoma based on elevated tumor marker serum levels. Clin Positron Imaging 2000;3:231-6 DOI ScienceOn |
17 | Belhocine T, Debarsy C, Hustinx R, Willems-Foidart J. Usefulness of -FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 2002;9:1132-9 |
18 | Pelosi E, Messa C, Sironi S, Picchio M, Landoni C, Bettinardi V, et al. Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging 2004;31:932-9 DOI PUBMED ScienceOn |
19 | Forstner R, Hricak H, Powell CB, Azizi L, Frankel SB, Stem JL. Ovarian cancer recurrence: value of MR imaging. Radiology 1995;196:1131-40 PUBMED |
20 | Zimny M, Siggelkow W, Schroder W, Nowak B, Biemann S, Rath W, et al. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 2001;83:310-5 DOI ScienceOn |
21 | Sun SS, Chen TC, Yen RF, Shen YY, Changlai SP, Kao A Value of whole body F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Anticancer Res 2000;21:2957-61 |
22 | Annual report of gynecologic cancer registry program in Korea for 2002 (2002.1.1-2002.12.31). Korean J Obstet Gynecol 2004;47:1029-70 |
23 | Reinartz P, Wieres FJ, Schneider W, Schur A, Buell U. Side-byside reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT. Eur J Nucl Med Mol Imaging 2004;31:1456-61 DOI ScienceOn |
24 | Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, et al. Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics 2002;22:5-17 DOI PUBMED ScienceOn |
25 | Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004;231:305-32 DOI ScienceOn |
26 | Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004;22:4357-68 DOI ScienceOn |
27 | Kitajima K, Murakami K, Yamasaki E, Hagiwara S, Fukasawa I, Inaba N, et al. Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer. Ann Nucl Med 2008;22:103-9 DOI ScienceOn |